跳至主要内容
临床试验/NCT01926925
NCT01926925已完成不适用

Endothelial Function in Hispanic Children/Adolescents at Risk for Type 2 Diabetes

Joslin Diabetes Center0 个研究点目标入组 38 人开始时间: 2001年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
38
主要终点
Plasma levels of markers of endothelial activation and vascular inflammation

研究概览

简要总结

Type 2 diabetes is now more frequent in children/adolescents, especially in those from minority populations, including Hispanic Americans (HA). Diabetes and the pre-diabetes state markedly increase the risk of cardiovascular disease. Endothelial dysfunction is seen in the earliest stages of atherogenesis, which ultimately leads to cardiovascular disease. The main aim of this study is to evaluate the endothelial function in HA children/adolescents who are at risk for developing type 2 diabetes (obese children/adolescents from the Hispanic population).

The investigators' hypothesis is that endothelial dysfunction is present in this population and that it is associated with metabolic abnormalities linked to the insulin resistance syndrome. The investigators will study 2 groups of 15 individuals each, age 10-18 years. Group 1 will consist of obese (body mass index greater than 85th percentile for age and sex) Hispanic American children/adolescents and group 2 will consist of healthy, non-overweight (body mass index between the 25th and 50 th percentile for age and sex) Hispanic American children/adolescents.

The study will be carried out at the Joslin Diabetes Center. During the first day, participants will have a medical history and full physical examination, a standard OGTT and measurement of blood cell count, plasma glucose, insulin, lipids, HbA1c, BUN, creatinine, electrolytes, estradiol, testosterone, free fatty acids, CRP, endothelial markers, urinary microalbumin and hCG, if appropriate. An OGTT will be performed in order to rule out IGT or Diabetes. Estimations of insulin secretion and insulin sensitivity will be assessed using the homeostasis model assessment (HOMA). In the second day, the body composition and the brachial artery vasodilatory response to hyperemia will be assessed. Those found with diabetes will be tested for GAD-65 and IA2.

The investigators' hypothesis is that Hispanic American children/adolescents at risk for type 2 diabetes have impaired endothelial function and vascular reactivity that are associated with the degree of insulin resistance and its metabolic abnormalities.

详细描述

Information as above

研究设计

研究类型
Observational
时间视角
Cross Sectional

入排标准

年龄范围
10 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 10-18 years;
  • Hispanic (we will consider a subject being Hispanic if both parents are reported as Hispanics when asked the following question: "What ethnic group do you consider that you belong to?");
  • No history of type 2 diabetes in any first-degree relative;
  • Body mass index between the 25th and 50th percentile for age and sex
  • Not have participated in any exercise program for the 6 months prior to the beginning of the study.
  • Age between 10-18 years;
  • Hispanic (same criteria as above);
  • Body mass index greater than the 85th percentile for age and sex;
  • Not have participated in any exercise program for the 6 months prior to the beginning of the study.

排除标准

  • The exclusion criteria include: diabetes, pregnancy, smoking, cardiovascular disease, uncontrolled hypertension, renal disease, proteinuria, cancer, infectious diseases, severe GI diseases, lung disease, electrolyte abnormalities, anemia, endocrine disorders, severe dyslipidemia, peripheral vascular disease, medications: beta-blockers, any diuretic, calcium channel blockers, ACE inhibitors, niacin, glucocorticoids, any antineoplastic agent, antibiotics, psychoactive agents, bronchodilators or insulin.

结局指标

主要结局

Plasma levels of markers of endothelial activation and vascular inflammation

时间窗: cross sectional study - one time evaluation

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Enrique Caballero

Clinical Investigator/Director Latino Diabetes Initiative

Joslin Diabetes Center

相似试验